The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation.
Open accessAbstract
Nuclear factor kappa B (NF-kappa B) is a critical regulator of several genes which are involved in immune and inflammation responses. NF-kappa B, consisting of a 50-kDa protein (p50) and a 65-kDa protein (p65), is bound to a cytoplasmic retention protein called I kappa B. Stimulation of cells with a variety of inducers, including cytokines such as tumor necrosis factor and interleukin-1, leads to the activation and the translocation of p50/65 NF-kappa B into the nucleus. However, the in vivo mechanism of the activation process remains unknown. Here, we provide the first evidence that the in vivo mechanism of NF-kappa B activation is through the phosphorylation and subsequent loss of its inhibitor, I kappa B alpha. We also show that both I kappa B alpha loss and NF-kappa B activation are inhibited in the presence of antioxidants, demonstrating that the loss of I kappa B alpha is a prerequisite for NF-kappa B activation. Finally, we demonstrate that I kappa B alpha is rapidly resynthesized after loss, indicating that an autoregulatory mechanism is involved in the regulation of NF-kappa B function. We propose a mechanism for the activation of NF-kappa B through the modification and loss of I kappa B alpha, thereby establishing its role as a mediator of NF-kappa B activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schreck, R., Rieber, P., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07761.x · Cited by 3,816
Interleukin-1 and interleukin-1 antagonism
Dinarello, C. (1991) · Blood · doi:10.1182/blood.v77.8.1627.1627 · Cited by 2,304
IκB: a Specific Inhibitor of the NF-κB Transcription Factor
Baeuerle, P. A., & Baltimore, D. (1988) · Science · doi:10.1126/science.3140380 · Cited by 2,155
The Pathophysiology Of Tumor Necrosis Factors
VASSALLI, P. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.411 · Cited by 1,920
Osborn, L., Kunkel, S., & Nabel, G. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2336 · Cited by 1,621
Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.
Schreck, R., Meier, B., Männel, D. N., Dröge, W., & Baeuerle, P. A. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1181 · Cited by 1,508
Activation in vitro of NF-κB" by phosphorylation of its inhibitor IκB"
Ghosh, S., & Baltimore, D. (1990) · Nature · doi:10.1038/344678a0 · Cited by 1,172
Baeuerle, P. A., & Baltimore, D. (1988) · Cell · doi:10.1016/0092-8674(88)90382-0 · Cited by 1,166
Schütze, S., Potthoff, K., Machleidt, T., Berkovic, D., Wiegmann, K., & Krönke, M. (1992) · Cell · doi:10.1016/0092-8674(92)90553-o · Cited by 1,046
Staal, F. J., Roederer, M., Herzenberg, L. A., & Herzenberg, L. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.9943 · Cited by 957
IMF-κB and Rel: Participants in a Multiform Transcriptional Regulatory System
Grilli, M., Chiu, J. J.-S., & Lenardo, M. J. (1993) · International Review of Cytology · doi:10.1016/s0074-7696(08)61873-2 · Cited by 936
Kieran, M., Blank, V., Logeat, F., Vandekerckhove, J., Lottspeich, F., Le Bail, O., Urban, M. B., Kourilsky, P., Baeuerle, P. A., & Israël, A. (1990) · Cell · doi:10.1016/0092-8674(90)90275-j · Cited by 874
Cloning of the p50 DNA binding subunit of NF-κB: Homology to rel and dorsal
Ghosh, S., Gifford, A. M., Riviere, L. R., Tempst, P., Nolan, G. P., & Baltimore, D. (1990) · Cell · doi:10.1016/0092-8674(90)90276-k · Cited by 852
Duh, E. J., Maury, W. J., Folks, T. M., Fauci, A. S., & Rabson, A. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5974 · Cited by 767
Haskill, S., Beg, A. A., Tompkins, S. M., Morris, J. S., Yurochko, A. D., Sampson-Johannes, A., Mondal, K., Ralph, P., & Baldwin, A. S. (1991) · Cell · doi:10.1016/0092-8674(91)90022-q · Cited by 732
Self-citationBeg, A. A., Ruben, S. M., Scheinman, R. I., Haskill, S., Rosen, C. A., & Baldwin, A. S. (1992) · Genes & Development · doi:10.1101/gad.6.10.1899 · Cited by 718
Self-citationDNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide
Nolan, G. P., Ghosh, S., Liou, H.-C., Tempst, P., & Baltimore, D. (1991) · Cell · doi:10.1016/0092-8674(91)90320-x · Cited by 596
Stein, B., Rahmsdorf, H. J., Steffen, A., Litfin, M., & Herrlich, P. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.11.5169 · Cited by 524
A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB.
Baeuerle, P. A., & Baltimore, D. (1989) · Genes & Development · doi:10.1101/gad.3.11.1689 · Cited by 505
Kunsch, C., Ruben, S. M., & Rosen, C. A. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.10.4412-4421.1992 · Cited by 488
Dressler, K. A., Mathias, S., & Kolesnick, R. N. (1992) · Science · doi:10.1126/science.1313189 · Cited by 440
Isolation of a rel -related Human cDNAThat Potentially Encodes the 65-kD Subunit of NF-κB
Ruben, S. M., Dillon, P. J., Schreck, R., Henkel, T., Chen, C.-H., Maher, M., Baeuerle, P. A., & Rosen, C. A. (1991) · Science · doi:10.1126/science.2006423 · Cited by 439
The precursor of NF-κB p50 has IκB-like functions
Rice, N. R., MacKichan, M. L., & Israël, A. (1992) · Cell · doi:10.1016/0092-8674(92)90353-e · Cited by 403
Henkel, T., Zabel, U., van Zee, K., Müller, J. M., Fanning, E., & Baeuerle, P. A. (1992) · Cell · doi:10.1016/0092-8674(92)90083-o · Cited by 385
Shirakawa, F., & Mizel, S. B. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.6.2424-2430.1989 · Cited by 380
A simple, rapid method for the purification of poly A+ RNA.
Badley, J. E., Bishop, G. A., John, T. S., et al. (1988) · PubMed · Cited by 379
Characterization of a ceramide-activated protein kinase: stimulation by tumor necrosis factor alpha.
Mathias, S., Dressler, K. A., & Kolesnick, R. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10009 · Cited by 366
Bours, V., Villalobos, J., Burd, P. R., Kelly, K., & Siebenlist, U. (1990) · Nature · doi:10.1038/348076a0 · Cited by 321
The candidate oncoprotein Bcl-3 is an antagonist of pSO/NF-κB-mediated inhibition
Franzoso, G., Bours, V., Park, S., Tomfta-Yamaguchi, M., Kelly, K., & Siebenlist, U. (1992) · Nature · doi:10.1038/359339a0 · Cited by 319
The v-rel oncogene encodes a κB enhancer binding protein that inhibits NF-κB function
Ballard, D. W., Walker, W. H., Doerre, S., Sista, P., Molitor, J. A., Dixon, E. P., Peffer, N. J., Hannink, M., & Greene, W. C. (1990) · Cell · doi:10.1016/0092-8674(90)90146-6 · Cited by 313
Generation of p50 subunit of NF-kB by processing of p105 through an ATP-dependent pathway
Fan, C.-M., & Maniatis, T. (1991) · Nature · doi:10.1038/354395a0 · Cited by 305
Ballard, D. W., Dixon, E. P., Peffer, N. J., Bogerd, H., Doerre, S., Stein, B., & Greene, W. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1875 · Cited by 278
Israël, A., Le Bail, O., Hatat, D., Piette, J., Kieran, M., Logeat, F., Wallach, D., Fellous, M., & Kourilsky, P. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08556.x · Cited by 271
IκBγ, a 70 kd protein identical to the C-terminal half of p110 NF-κB: A new member of the IκB family
Inoue, J.-I., Kerr, L. D., Kakizuka, A., & Verma, I. M. (1992) · Cell · doi:10.1016/0092-8674(92)90082-n · Cited by 269
Ten, R. M., Paya, C. V., Israël, N., Le Bail, O., Mattei, M. G., Virelizier, J. L., Kourilsky, P., & Israël, A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05042.x · Cited by 251
Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-κB
Wulczyn, F. G., Naumann, M., & Scheidereit, C. (1992) · Nature · doi:10.1038/358597a0 · Cited by 245
Rel-Associated pp40: an Inhibitor of the Rel Family of Transcription Factors
Davis, N., Ghosh, S., Simmons, D. L., Tempst, P., Liou, H.-C., Baltimore, D., & Bose, H. R. (1991) · Science · doi:10.1126/science.1891714 · Cited by 240
Hatada, E. N., Nieters, A., Wulczyn, F. G., Naumann, M., Meyer, R., Nucifora, G., McKeithan, T. W., & Scheidereit, C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2489 · Cited by 233
Lowenthal, J. W., Ballard, D. W., Böhnlein, E., & Greene, W. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2331 · Cited by 221
Kerr, L. D., Inoue, J., Davis, N., Link, E., Baeuerle, P. A., Bose, H. R., & Verma, I. M. (1991) · Genes & Development · doi:10.1101/gad.5.8.1464 · Cited by 202
The inhibitory ankyrin and activator Rel proteins
Nolan, G. P., & Baltimore, D. (1992) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(05)80276-x · Cited by 183
Blank, V., Kourilsky, P., & Israël, A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04994.x · Cited by 178
Ruben, S. M., Narayanan, R., Klement, J. F., Chen, C. H., & Rosen, C. A. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.2.444 · Cited by 170
A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon.
Brownell, E., Mittereder, N., & Nr, R. (1989) · PubMed · Cited by 169
Inoue, J., Kerr, L. D., Rashid, D. J., Davis, N., Bose, H. R., & Verma, I. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4333 · Cited by 133
The physiology of the NF-κB transcription factor
Baeuerle, P. A., & Baltimore, D. (1991) · Molecular aspects of cellular regulation · doi:10.1016/b978-0-444-81382-4.50026-8 · Cited by 83
Bomsztyk, K., Rooney, J. W., Iwasaki, T., Rachie, N. A., Dower, S., & Sibley, C. H. (1991) · Cell Regulation · doi:10.1091/mbc.2.4.329 · Cited by 64
The inhibitory ankyrin and activator Rel proteins
Nolan, G. P., & Baltimore, D. (1992) · Current Biology · doi:10.1016/0960-9822(92)90380-s · Cited by 18
Cited by
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Reactive oxygen species in cancer
Liou, G.-Y., & Storz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,382
Palombella, V. J., Rando, O. J., Goldberg, A. L., & Maniatis, T. (1994) · Cell · doi:10.1016/s0092-8674(94)90482-0 · Cited by 2,096
Hsu, H., Shu, H.-B., Pan, M.-G., & Goeddel, D. V. (1996) · Cell · doi:10.1016/s0092-8674(00)80984-8 · Cited by 1,998
Metadata
- Authors
- Beg, A. A., Finco, T. S., Nantermet, P. V., & Baldwin, A. S.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1993-06
- Volume
- 13
- Issue
- 6
- Pages
- 3301-3310
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2105896882
- Cited by
- 1,027
- References
- 48
- FWCI
- 44.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.